Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.825 USD | -1.91% | -15.49% | +21.67% |
Mar. 20 | North American Morning Briefing : Markets on Hold -2- | DJ |
Mar. 19 | JPMorgan Upgrades Mersana Therapeutics to Neutral From Underweight, Price Target is $5 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.67% | 349M | |
-1.95% | 104B | |
+1.82% | 97.42B | |
+0.79% | 22.2B | |
-17.71% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.36% | 15.06B | |
+3.59% | 13.98B | |
+33.39% | 11.66B |
- Stock Market
- Equities
- MRSN Stock
- News Mersana Therapeutics, Inc.
- Mersana Therapeutics Q3 Loss Widens, Collaboration Revenue Unchanged